Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Inflation hikes up care home costs

How will the care home sector cope with the wave of inflation now hitting it as staff, energy costs and rents soar? We talk to operators and advisers across Europe.
May 20, 2022

European nursing homes – a five market comparison

This week we take a closer look at how the elderly residential nursing home market stacks up, specifically in five major European markets - France, Spain, Germany, Italy and UK. Here we compare the total, and for profit and public/not-for-profit market revenues, and look at where the international operators have the largest revenues. These figures are a snapshot of the position based on revenues in 2020 taken from our nursing homes reports in HBI Intelligence and the operator database.
May 13, 2022

German government pushing ahead with cannabis legalisation

The German health minister is pressing ahead with plans to legalise cannabis, despite concerns from some quarters that it could be challenged at the EU level, and unresolved questions about what the regulatory framework will look like. HBI speaks to legal and policy experts, and hears that medical cannabis producers have an early adopter advantage against potential rivals - and there are health implications if legislation passes.
May 13, 2022

Sanoptis sells to unexpected buyer

As predicted by HBI earlier this year, fast-growing German and Swiss ophthalmology group Sanoptis has sold - but to an unexpected buyer. Owner Telemos Capital has signed an agreement to sell to family-backed investment holding company Groupe Bruxelles Lambert (GBL), the same group which has also just agreed to buy a majority stake in European imaging and cancer treatment provider Affidea.
April 21, 2022

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
April 19, 2022

Artemis founder speaks out after damning documentary on primetime TV

A primetime ‘exposé’ of how private equity operates in the German ophthalmology market had some of its largest operators in its crosshairs last week. We talk to the founder of Artemis Augenkliniken, who was interviewed on camera, and a specialist healthcare lawyer, for their take on hitting the headlines for the wrong reasons.
April 14, 2022

Karl Lauterbach u-turns on voluntary quarantine and loses mandatory vaccine vote

Last week was a rough one for German health minister Karl Lauterbach. First he made an embarrassing u-turn on his decision to end mandatory Covid quarantines and then his government's proposal to introduce mandatory vaccinations, which he has been championing since entering office, was rejected by legislators.
April 14, 2022

For-profit dentistry consolidation in Europe

This week, we look at the extent to which the for-profit dentistry market is consolidated in five major European countries – France, Germany, UK, Spain and Italy. These figures are a snapshot of the position based on revenues in 2020 taken from HBI Intelligence - and show why interest in dentistry is so high.
April 14, 2022

Fresenius Helios launches revolutionary primary care offer

Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.
April 8, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us